Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or
A phase 3 trial of Rinatabart sesutecan, Bevacizumab, Carboplatin in ovarian cancer, run by Genmab, now recruiting.
Overview
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer is a phase 3 interventional study registered as NCT07564141 by Genmab, with 688 participants planned, started 2026-08-28 and due to reach its primary completion in 2029-12. Interventions recorded: Rina-S, Bevacizumab, Carboplatin, Gemcitabine, Paclitaxel. Conditions listed: Platinum-Sensitive Ovarian Cancer, Ovarian Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialStudy to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Re
Shares Rinatabart sesutecan, Genmab, Bevacizumab, Ovarian cancer.
- TrialStudy to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Shares Rinatabart sesutecan, Genmab, Gemcitabine, Paclitaxel / nab-paclitaxel.
- TrialAn Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Can
Shares Rinatabart sesutecan, Genmab, Gemcitabine, Paclitaxel / nab-paclitaxel.
- TrialA Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Shares Gemcitabine, Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin.
- TrialStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Shares Rinatabart sesutecan, Genmab.
- TrialRAINFOL-01 (Rina-S)
Shares Rinatabart sesutecan, Genmab, Ovarian cancer.
- TrialOregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.
- TrialPhase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Ovarian cancer.